BASF Faces a Summer of Reckoning as Buyback Support Fades and Zhanjiang's Promise Lingers
13.06.2026 - 13:44:59 | boerse-global.de
The market's patience for BASF is running thin. The stock closed at €49.35 on Friday, down nearly 9% over the past month, and the primary support mechanism that propped it up for months is about to disappear. By the end of June 2026, the first tranche of the company's share repurchase program — worth up to €1.5 billion — will be exhausted. Without that steady structural buyer in the market, the focus shifts squarely to operating performance.
What's left is a multibillion-euro bet on a single location: Zhanjiang. BASF opened the complex in March at a cost of roughly €8.7 billion, with 18 plants, 32 production lines and more than 70 products ranging from basic chemicals to specialty compounds for transport, electronics and consumer goods. The steamcracker was ramped up in record time, and the first value chains started running around the turn of the year. But ribbon-cutting ceremonies don't generate cash flows. The market wants to see earnings, not construction milestones.
CEO Markus Kamieth has already warned that near-term profits will remain subdued. Overcapacity across the industry and persistently high energy prices continue to weigh on the sector. The paradox for BASF: it is doubling down on China as a growth market at the same time as Chinese competitors are squeezing European producers' margins with cheap exports. Goldman Sachs analyst Georgina Fraser recently published a sector study forecasting another downturn for Europe's chemical industry, arguing that the demand decline had arrived "more sharply and faster" than expected.
Should investors sell immediately? Or is it worth buying BASF?
The strategic response from management is called "CoreShift" — a program to cut fixed costs in the core business by a fifth by 2029, overseen by a newly established Core Transformation Office. At the same time, the company is tidying up its global production network: the EPS plant in Ulsan, South Korea, will close in mid-June, and the silicate business is being sold to PQ Corporation. Portfolio pruning is necessary, but it doesn't create a new growth driver. Cost savings are expected to reach €2.3 billion by the end of 2026, yet that alone can't compensate for the loss of buyback-driven demand.
The share price reflects the uncertainty. At €49.35, it trades below the 50-day moving average of €52.14, while the 200-day average at €46.95 provides the nearest floor. The 52-week high of €55.05 is now more than 10% out of reach. The relative strength index of 42.2 signals no panic, but also no buying urgency. April's high is already looking distant.
For patient holders, there is a dividend floor: at least €2.25 per share for the current financial year, part of a broader payout and buyback plan through 2028. Kamieth maintains that the second quarter can meet analyst expectations, though he cautioned that the short-lived demand bump seen in March has faded. The full-year guidance for operating earnings between €6.2 billion and €7.0 billion remains intact.
The real test comes with the half-year report in July. Until then, the stock is likely to drift in a range — supported by the dividend yield, but pressured by sector headwinds and the absence of buyback tailwind. Zhanjiang is the strategic answer for decades; the market is asking about quarters.
Ad
BASF Stock: New Analysis - 13 June
Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
